Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001943192-26-000001 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 4, 2026 |
| Document Date | Jan 31, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
110,372
Total Value
$232,613.04
P&L
+inf% (+$2,858,763.60)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF FINANCIAL OFFICER | Common Stock | โ | Jan 31, 2026 | Grant/Award | 28,130 | $0.00 | $0.00 | 120,213 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Common Stock | โ | Feb 3, 2026 | Sale | 7,242 | $32.12 | $232,613.04 | 112,971 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Employee stock option (right to buy) | Derivative | Jan 31, 2026 | Grant/Award | 75,000 | $0.00 | $0.00 | 75,000 | Direct | โ | View Details |